Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic.

导出 OA

翻译打印收藏纠错

第一作者： Selin,Küçükyurt

第一单位： Division of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey.

作者： Selin,Küçükyurt ^[1] ; Kübra,Şahin ^[2] ; Umut,Yılmaz ^[1] ; Abdülkadir,Erçalışkan ^[1] ; Tuba,Özkan Tekin ^[1] ; Damla,Ortaboz ^[1] ; Tuğrul,Elverdi ^[1] ; Ayşe,Salihoğlu ^[1] ; Muhlis Cem,Ar ^[1] ; Şeniz,Öngören ^[1] ; Zafer,Başlar ^[1] ; Ahmet Emre,Eşkazan ^[3]

作者单位： Division of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey. ^[1] Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey. ^[2] Division of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey. Electronic address: emre.eskazan@iuc.edu.tr. ^[3]

关键词 COVID-19 Diagnosis-to-treatment interval Diagnostic delay Hodgkin lymphoma Management SARS-CoV-2 Symptom-to-diagnosis interval

主题词人类(Humans);疾病大流行(Pandemics);霍奇金病(Hodgkin Disease)

DOI 10.1016/j.currproblcancer.2022.100913

PMID 36399974

发布时间 2023-01-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交